Clinical Trial Update: A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia [Phase 2]

View source ↗

Summary

This document announces a Phase 2 clinical trial evaluating Obecabtagene Autoleucel for B-cell acute lymphoblastic leukemia, with recruitment ongoing. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• Obecabtagene Autoleucel

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Acute Lymphoblastic Leukemia | Phase 2 | Status: RECRUITING